BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26663814)

  • 1. Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis.
    Movahedi M; Beauchamp ME; Abrahamowicz M; Ray DW; Michaud K; Pedro S; Dixon WG
    Arthritis Rheumatol; 2016 May; 68(5):1089-98. PubMed ID: 26663814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
    Ozen G; Pedro S; Holmqvist ME; Avery M; Wolfe F; Michaud K
    Ann Rheum Dis; 2017 May; 76(5):848-854. PubMed ID: 27836820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort study.
    Movahedi M; Costello R; Lunt M; Pye SR; Sergeant JC; Dixon WG
    Eur J Epidemiol; 2016 Oct; 31(10):1045-1055. PubMed ID: 27256352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study.
    Pujades-Rodriguez M; Morgan AW; Cubbon RM; Wu J
    PLoS Med; 2020 Dec; 17(12):e1003432. PubMed ID: 33270649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Incident Type 2 Diabetes Mellitus Among Patients With Rheumatoid Arthritis: A Population-Based Cohort Study.
    Jin Y; Chen SK; Liu J; Kim SC
    Arthritis Care Res (Hoboken); 2020 Sep; 72(9):1248-1256. PubMed ID: 32754989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid use is associated with an increased risk of hypertension.
    Costello RE; Yimer BB; Roads P; Jani M; Dixon WG
    Rheumatology (Oxford); 2021 Jan; 60(1):132-139. PubMed ID: 32596721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis.
    Dixon WG; Abrahamowicz M; Beauchamp ME; Ray DW; Bernatsky S; Suissa S; Sylvestre MP
    Ann Rheum Dis; 2012 Jul; 71(7):1128-33. PubMed ID: 22241902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study.
    Aviña-Zubieta JA; Abrahamowicz M; De Vera MA; Choi HK; Sayre EC; Rahman MM; Sylvestre MP; Wynant W; Esdaile JM; Lacaille D
    Rheumatology (Oxford); 2013 Jan; 52(1):68-75. PubMed ID: 23192907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Risk of Glucocorticoid-Associated Adverse Effects in Patients With Rheumatoid Arthritis.
    Wilson JC; Sarsour K; Gale S; Pethö-Schramm A; Jick SS; Meier CR
    Arthritis Care Res (Hoboken); 2019 Apr; 71(4):498-511. PubMed ID: 29856128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink.
    Abtahi S; Driessen JHM; Burden AM; Souverein PC; van den Bergh JP; van Staa TP; Boonen A; de Vries F
    Rheumatology (Oxford); 2022 Apr; 61(4):1448-1458. PubMed ID: 34255815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study.
    Davis JM; Maradit Kremers H; Crowson CS; Nicola PJ; Ballman KV; Therneau TM; Roger VL; Gabriel SE
    Arthritis Rheum; 2007 Mar; 56(3):820-30. PubMed ID: 17330254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing effects of rheumatoid arthritis and low dose prednisolone on arginine metabolomics.
    Radhakutty A; Mangelsdorf BL; Drake SM; Rowland A; Smith MD; Mangoni AA; Thompson CH; Burt MG
    Atherosclerosis; 2017 Nov; 266():190-195. PubMed ID: 29035782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine use and decreased risk of diabetes in rheumatoid arthritis patients.
    Bili A; Sartorius JA; Kirchner HL; Morris SJ; Ledwich LJ; Antohe JL; Dancea S; Newman ED; Wasko MC
    J Clin Rheumatol; 2011 Apr; 17(3):115-20. PubMed ID: 21441823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T; Nakamura H
    Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.
    Peters MJ; van Halm VP; Voskuyl AE; Smulders YM; Boers M; Lems WF; Visser M; Stehouwer CD; Dekker JM; Nijpels G; Heine R; Dijkmans BA; Nurmohamed MT
    Arthritis Rheum; 2009 Nov; 61(11):1571-9. PubMed ID: 19877093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis.
    Schenfeld J; Iles J; Trivedi M; Accortt NA
    Rheumatol Int; 2017 Jul; 37(7):1075-1082. PubMed ID: 28255642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids Are Associated with an Increased Risk for Vertebral Fracture in Patients with Rheumatoid Arthritis.
    Kim D; Cho SK; Park B; Jang EJ; Bae SC; Sung YK
    J Rheumatol; 2018 May; 45(5):612-620. PubMed ID: 29545455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes.
    Douros A; Abrahami D; Yin H; Yu OHY; Renoux C; Hudson M; Azoulay L
    Epidemiology; 2018 Nov; 29(6):904-912. PubMed ID: 30028343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid.
    Sugiyama T; Suzuki S; Yoshida T; Suyama K; Tanaka T; Sueishi M; Tatsuno I
    Gend Med; 2010 Jun; 7(3):218-29. PubMed ID: 20638627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.
    Lillegraven S; Greenberg JD; Reed GW; Saunders K; Curtis JR; Harrold L; Hochberg MC; Pappas DA; Kremer JM; Solomon DH
    PLoS One; 2019; 14(1):e0210459. PubMed ID: 30673733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.